Skip to main content

Table 1 Clinical and biochemical variables in controls and patients with NAFLD

From: Significant decrease of saturation index in erythrocytes membrane from subjects with non-alcoholic fatty liver disease (NAFLD)

 

Controls (n = 24) mean ± SD

Moderate NAFLD (n = 30) mean ± SD

Severe NAFLD (n = 47) mean ± SD

P value

Age

50.8 ± 8.4

50.5 ± 10.6

50.5 ± 10.6

0.4

BMI

30.9 ± 3.2

30.7 ± 2.9

32.3 ± 4.9

0.02 Controls vs Severe

Azotemia

21.5 ± 21.5

36.4 ± 10.2

34.6 ± 9.8

0.001 Controls vs Moderate and Severe

Ferritin

114.7 ± 148.6

137.9 ± 142.2

149.4 ± 178.9

0.42

ALT

28.9 ± 20.4

29.2 ± 10.3

40.7 ± 23.0

0.02 Controls vs Severe

AST

21.91 ± 4.18

23.53 ± 4.91

29.37 ± 10.84

0.01 Controls vs Severe

GGT

29.9 ± 46.5

23.5 ± 12.1

31.9 ± 28.3

0.8

Total cholesterol

198.6 ± 33.3

210.6 ± 33.9

208.6 ± 35.9

0.28

Cholesterol- HDL

51.6 ± 13.2

48.1 ± 13.7

41.1 ± 8.3

0.001 Controls vs Severe

Triglycerides

100.7 ± 46.5

118.7 ± 69.1

151.2 ± 89.0

0.01 Controls vs Severe

Glycemia

87.4 ± 12.2

93.2 ± 6.0

98.8 ± 15.1

0.001 Controls vs Severe

Serum Insulin

7.18 ± 3.03

9.65 ± 3.96

13.2 ± 4.8

0.04 and 0.001 Controls vs Moderate and Severe, respectively

HOMA index

1.59 ± 0.72

2.22 ± 0.90

3.16 ± 1.27

0.04 and 0.001 Controls vs Moderate and Severe, respectively

SFAs

52.6 ± 8.8

52.3 ± 9.6

53.1 ± 10.9

0.84

MUFAs

22.4 ± 5.5

22.6 ± 6.2

22.0 ± 7.2

0.8

PUFAs

24.9 ± 5.7

25.0 ± 4.6

24.8 ± 5.6

0.9